Quick links

Secure login

Secure file transfer protocol

Register or renew user


Contact us

Trouble logging in? Forgot password? We can help!

philavax@phila.gov

215-685-6784

215-238-6944


Register a clinic

Fill out both forms, then either email or fax them to us at the contact above.

Clinic registration form
Enity confidentiality form

On behalf of patients

Patient update request

Looking for something else?

PhilaVax program info
Flat file reporting guide
More PhilaVax resources

Author: Rishi Sharma

October 29: 2024 PIC Conference Save the date! Join us for the Philadelphia Immunization Coalition’s Fall 2024 Conference. Our speakers will include Dr. Andrew Kroger (CDC) and Dr. Paul Offit (CHOP), among others to be announced. Topics covered will include COVID-19, RSV, flu, universal recommendations forcommunity outreach, vaccine...

Join Us for a COVID-19 Product Update Join the PDPH Immunization Program and our pharmaceutical partners for a virtual townhall regarding the 2024 - 2025 COVID-19 product update. This informative session is for both pediatric and adult primary care providers (PCPs) who would like to learn...

2024 -2025 VFC & VFAAR Flu Products 2024-2025 VFC & VFAAR products will be available to order soon. Make sure your office is ready!  Flulaval will be available to order for your VFC-eligible patients starting Tuesday, August 20, 2024.  Start the conversation about the importance of flu vaccination...

Lunch & Learn: Respiratory Viruses Join us for an informative virtual session on respiratory viruses. This session is for both pediatric and adult primary care physicians (PCPs) who would like to learn more about respiratory syncytial virus (RSV), influenza (flu), COVID-19, and what to know and expect...

Vaccine Product Available Through VFC: Jynneos Jynneos (Bavarian Nordic) vaccine is now available through the VFC program. It has been approved and recommended by the CDC and ACIP to prevent mpox (formerly monkeypox). VFC-eligible patients, 18 years of age only, can be vaccinated with these doses. Patients...

2023-2024 Pfizer (5 yrs-11 yrs and 12+) COVID-19 Vaccines No Longer Available  As of Monday, June 10, 2024, the Pfizer 2023-2024 COVID-19 vaccine, 5 yrs – 11 yrs, and Comirnaty (Pfizer), 2023-2024 COVID-19 vaccine, 12 yrs + products are no longer available to order through the Vaccines for Children...

Novavax COVID-19 Vaccine Now Expired! Read on for more upcoming changes in COVID-19 product availability. As of Friday, May 31, 2024 all doses of Novavax COVID-19 vaccine have expired.  Remove any remaining doses from your storage units at this time. Use this guide to waste any opened vaccine.  Use this guide to return unopened...

Call for Nominations: 2024 Immunization Champion Award  You can still submit a nomination for the Immunization Champion Award! Your nominations will determine the 2024 Philadelphia Immunization Champion. Check out the eligibility criteria below and acknowledge someone you know who champions local immunization access. The Immunization Champion Award is...

2023-2024 COVID-19 Vaccine Update Dosing Schedule & Available Products Review the dosing schedule and available products for 2023-2024 COVID-19 vaccine below. We don’t yet know the exact timing of when 2024–2025 COVID-19 vaccines will be available. However, FDA authorization or approval of 2024–2025 COVID-19 vaccines is anticipated...

COVID-19 Vaccine Return Guidance Unopened vaccines should be returned when:  The manufacturer expiration date has passed.  The vaccines are no longer viable due to out-of-range temperatures.  The vaccine has passed its beyond-use-date (BUD). When returning COVID-19 vaccines that have passed their beyond-use-date, remember to select Other as the return reason and include “Past...

Register for the SexMed Conference! Join this free, in-person conference designed for healthcare providers and care teams seeking best practices, protocols, and skills in proactive, patient-centered sexual healthcare for all Philadelphians. The conference will take place on Friday, May 3, 2024 in Center City, Philadelphia.  Register for the conference! Conference Details Fee There is...

Updated CDC Guidance for Community Settings Earlier this week, the CDC updated the respiratory virus guidance and suggested additional doses of the COVID-19 vaccine for those aged 65 and older.  The recommendations in this guidance may help reduce spread of respiratory illness such as RSV, influenza, and others. People in...

Lunch & Learn: Injection Safety Best Practices Join us for an informative, virtual session on Friday, February 2, 2024 from 12 to 1 p.m. This session is for outpatient providers. The Immunization Program is partnering with the Healthcare Associated Infections/Antimicrobial Resistance (HAI/AR) Program within the Division of Disease Control for this...

COVID-19 Vaccine Returns Unopened vaccines should be returned when:  The manufacturer expiration date has passed.  The vaccines are no longer viable due to out-of-range temperatures.  The vaccine has passed its beyond-use-date (BUD). When returning COVID-19 vaccines that have passed their beyond-use-date,remember to select Other as the return reason and include...

Mpox Vaccine: MLK Day Reminder The City of Philadelphia is closed on January 15, 2024 in observance of Martin Luther King Jr. Day. Be sure to submit your mpox vaccine requests by Tuesday, January 16 at 5 p.m. to account for the holiday. Normal deliveries resume...

Catch Up Pediatric Patients: MMR Vaccine There is a measles cluster in Philadelphia that started with an infant and spread to unvaccinated individuals. It has resulted in now 7 confirmed cases of measles among Philadelphia residents and an index case in Delaware county.To prevent further spread, review your...

New Beyond Use Date (BUD) Labels to Order New Beyond Use Date (BUD) labels are available for order. BUD labels can support your practice in ensuring vaccine is not used past expiration. These labels replace previous BUD labels intended for use with COVID-19 vaccine, and can...

Vaccine Product Available Through VFC: Abrysvo Abrysvo is a maternal RSV vaccine available through the Vaccines for Children (VFC) program.  RSV is surging and the pediatric infant immunization Beyfortus supply is severely limited. Abrysvo will play an important role in protecting infants against severe RSV disease this season. Most...